MIRA Pharmaceuticals, Inc. (MIRA:NASDAQ) closed at $0.660 on November 13, 2026, up 1.77% on the day. The stock trades 61.0% below its 52-week high of $1.69 and 29.4% above its 52-week low of $0.510. Over the past year, it lost 51.5%. MIRA Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, MIRA closed higher on 110 days (44%). Its best day was March 23, 2026 (+22.28%) and its worst was August 3, 2026 (-22.47%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 1 time.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Find more stocks like MIRA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.